Cara Therapeutics is a Connecticut-based biopharmaceutical company that researches and develops novel therapies for the treatment of pruritus... Read more
Cara Therapeutics is a Connecticut-based biopharmaceutical company that researches and develops novel therapies for the treatment of pruritus... Read more
News
Nov 14, 2025
Owler
Tvardi Therapeutics, Inc.: Tvardi Therapeutics's revenue had no change from Jun 2025 to Sep 2025
May 14, 2025
Owler
Cara Therapeutics, Inc.: Cara Therapeutics's revenue changed from $7.14M in Dec 2024 to $7.57M in Mar 2025
Apr 14, 2025
Citybizlist
Cara Therapeutics: Cara Therapeutics Announces 1-for-3 Reverse Stock Split
Mar 11, 2025
Owler
Cara Therapeutics, Inc.: Cara Therapeutics's revenue changed from $8.69M in Sep 2024 to $7.14M in Dec 2024
Feb 20, 2025
centralcharts
Press Release: Cara Therapeutics : CARA THERAPEUTICS INVESTOR ALERT by the Former Attorney General of Louisiana: Kahn Swick & Foti, LLC Investigates Merger of Cara Therapeutics, Inc.
Jan 07, 2025
Business Wire
Press Release: Cara Therapeutics : CARA THERAPEUTICS INVESTOR ALERT by the Former Attorney General of Louisiana: Kahn Swick & Foti, LLC Investigates Merger of Cara Therapeutics, Inc. - CARA
Dec 27, 2024
LD Micro
Press Release: Cara Therapeutics : Cara Therapeutics Announces Effective Date of 1-for-12 Reverse Stock Split
Dec 18, 2024
StreetInsider
Press Release: Cara Therapeutics : SHAREHOLDER ALERT: Rigrodsky Law, P.A. Is Investigating Cara Therapeutics, Inc. Merger
Dec 18, 2024
The Business Journals: Houston
Cara Therapeutics: Tvardi Therapeutics to go public in reverse merger with Connecticut company
Jul 11, 2024
BioSpace
Cara Therapeutics: Cara Therapeutics Announces Exploration of Strategic Alternatives
Tvardi Therapeutics Competitors
1
2
3
4
5
6
7
8